论文部分内容阅读
本文将甲亢(弥漫性甲状腺肿伴机能亢进症)患者17例随机分为针剌治疗组8例及口服他巴唑治疗组9例,分别治疗30天。治疗前后测血 TT_3、TT_4,rT_3、TGA 及 TMA,经统计学处理进行治疗前后纽间、组内自身对比及临庥疗效对比。结果显示:针剃组5/8例(62.5%)临床高代谢症状减轻,3/8例(37.5%)无改善;实验室结果显示治疗前后差异无显著意义(P>005)。服药组临床症状及实验室指标均有好转,治疗前后差异有显著意义(P<0.05)。临床观察到针剌有类似心得安的β受体阻滞作用,推测针剌伍用抗甲剂可增强疗效,兼有对症及病因治疗作用。
In this paper, 17 cases of hyperthyroidism (diffuse goiter with hyperthyroidism) were randomly divided into acupuncture treatment group of 8 patients and oral methimazole treatment group of 9 patients, respectively, for 30 days. The blood levels of TT_3, TT_4, rT_3, TGA and TMA were measured before and after treatment. The comparison between the two groups before and after treatment was statistically analyzed. The results showed that 5/8 patients (62.5%) in the needle shaving group had no clinical symptoms and no improvement in 3 of 8 patients (37.5%). The laboratory results showed no significant difference (P> 005) before and after treatment. The clinical symptoms and laboratory indexes of the medication group improved, with significant difference before and after treatment (P <0.05). Acupuncture has been clinically observed with similar propranolol β-blocker effect, suggesting that acupuncture with anti-arm agent can enhance the efficacy of both symptomatic and etiological treatment.